실시간 바이오 인텔리전스 · ADC · CGT

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

9,268+프로그램
35+FDA 승인
4,079+모집 중
ADC 1068·Antibody 5456·CGT 2744차세대 추천 →·Data Tier →
9268프로그램35FDA 승인
0오늘 방문
572누적 방문
8122갱신 대기S–CData TierS/A/B차세대1068HER2 breast5456Antibody2744CGT→Psoriasis→NSCLC35FDA 승인
피드Data Tier차세대

추천 비교

비교 도구 →
HER2 ADCEnhertu · Kadcyla · RC48CD19 CAR-TYescarta · KymriahPD-1Keytruda · Opdivo다발골수종Darzalex · BlenrepTROP2 ADCTrodelvy · Dato-DXd · SGNectin-4 · TROP2Padcev · Trodelvy건선 IL pathwayStelara · Cosentyx · SkyriziAnti-VEGF (안과)Eylea · LucentisAnti-TNFHumira · EnbrelIL-12/23Stelara · Skyrizi아토피·IL-13Dupixent · Ebglyss혈우병 유전자치료Hemgenix · Roctavian겸상적혈구 CGTCasgevy · Lyfgenia망막·DMD 유전자치료Luxturna · Elevidys

최근 활동

RSS →

빠른 검색 · 이슈 태그

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
다음 갱신 D-12 · 마지막 7월 13일
ADCBiologicstaleRochePhase 2

Polatuzumab Vedotin, Rituximab, Lenalidomide (Polatuzumab Vedotin, Rituximab, Lenalidomide)

Diffuse Large B Cell Lymphoma · Diffuse Large B Cell Lymphoma

#DiffuseLargeBCellLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 100%임상시험 12상태 RECRUITING
ADCBiologicstaleAmgenPhase 2

YL201 (YL201)

Small Cell Lung Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 12상태 RECRUITING
ADCBiologicstaleMediLink Therapeutics (Suzhou) …Phase 2

YL-201 (YL-201)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 12상태 RECRUITING
CGTBiologicstaleiCell Gene TherapeuticsPhase 1

Anti-CD33 CAR T-cells (Anti-CD33 CAR T-cells)

Acute Myeloid Leukemia; Recurrent Adult Acute Myeloid Leukemia · CD33

#CD33#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 12상태 RECRUITING
CGTBiologicstaleBiohaven Pharmaceuticals, Inc.Phase 1

CIML-NK cell therapy (CIML-NK cell therapy)

Acute Myeloid Leukemia Refractory; Acute Myeloid Leukemia, in Relapse · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 12상태 RECRUITING
CGTBiologicstaleVyriad, Inc.Phase 2

Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter (Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter)

Fallopian Tube Clear Cell Adenocarcinoma; Fallopian Tube Endometrioid Adenocarcinoma · Fallopian Tube Clear Cell Adenocarcinoma

#FallopianTubeClearCellAdenocarci#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 0%임상시험 12상태 ACTIVE
AntibodyNational Cancer Centre, Singapo…Phase 2

atezolizumab (Tecentriq, Adjuvant Atezolizumab-Bevacizumab Therapy)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 12상태 RECRUITING
AntibodyAstraZenecaPhase 1

durvalumab (Imfinzi, Administration of ceralasertib and durvalumab)

Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer · Adv Solid Malig - H&N SCC, ATM Pro / Def

#AdvSolidMalig-HNSCCATMProDef#Antibody#Phase1#항체#면역항체+5
효능 ORR 9.5%임상시험 12상태 RECRUITING
AntibodystaleMerckPhase 2

pembrolizumab (Keytruda, Pembrolizumab/Quavonlimab)

Melanoma · Melanoma

#Melanoma#Antibody#Phase2#항체#면역항체+2
효능 ORR 0.0%임상시험 12상태 ACTIVE
ADCBiologicstaleShanghai Miracogen Inc.Phase 3

MRG002 (MRG002)

Advanced Breast Cancer; Metastatic Breast Cancer · Advanced or Metastatic Biliary Tract Can

#AdvancedorMetastaticBiliaryTract#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 12상태 ACTIVE
AntibodyAbbViePhase 2

Lutikizumab (Lutikizumab)

Ulcerative Colitis · Hidradenitis Suppurativa

#HidradenitisSuppurativa#Antibody#Phase2#항체#면역항체+4
효능 ORR 60%임상시험 12상태 RECRUITING
ADCBiologicstaleK-Group, Beta, Inc., a wholly o…Phase 1

Azenosertib (Azenosertib)

Clinical Stage III Gastric Cancer AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 · Clinical Stage III Gastric Cancer AJCC v

#ClinicalStageIIIGastricCancerAJC#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 12상태 RECRUITING
ADCBiologicstaleSuzhou Suncadia Biopharmaceutic…Phase 2

SHR-A2009 (SHR-A2009)

Advanced Breast Cancer; Metastatic Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 12상태 RECRUITING
ADCBiologicstaleJiangsu HengRui Medicine Co., L…Phase 2

Herombopag Olamine Tablets (Herombopag Olamine Tablets)

Thrombocytopenia · Thrombocytopenia

#Thrombocytopenia#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 12상태 RECRUITING
ADCBiologicstaleRochePhase 1

ado-trastuzumab emtansine (Kadcyla, T-DM1, PD-0332991 and T-DM1)

Advanced Breast Cancer · Advanced Breast Cancer

#AdvancedBreastCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 11상태 ACTIVE
ADCBiologicstaleRemeGen Co., Ltd.Phase 2

disitamab vedotin (Disitamab Vedotin, RC48, RC48 + Carboplatin)

Ovarian Cancer; HER2 · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 11상태 RECRUITING
CGTBiologicstaleCARsgen Therapeutics Co., Ltd.Phase 1

anti-GPC3 CAR-T (anti-GPC3 CAR-T)

Hepatocellular Carcinoma · Advanced Hepatocellular Carcinoma

#AdvancedHepatocellularCarcinoma#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 11상태 ACTIVE
AntibodystaleAmgenPhase 2

Panitumumab-IRDye800 (Panitumumab-IRDye800)

Pancreatic Adenocarcinoma · Malignant Brain Neoplasm

#MalignantBrainNeoplasm#Antibody#Phase2#항체#면역항체+3
임상시험 11상태 RECRUITING
AntibodystaleLepu Medical Technology (Beijin…Phase 2

MRG003+Pucotenlimab (MRG003+Pucotenlimab)

Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma · Locally Advanced Oral and Oropharyngeal

#LocallyAdvancedOralandOropharyng#Antibody#Phase2#항체#면역항체+2
임상시험 11상태 RECRUITING
AntibodystaleNeovii BiotechPhase 2

Transplant Conditioning with Mobilization and Alemtuzumab (Transplant Conditioning with Mobilization and Alemtuzumab)

Severe Combined Immunodeficiency · Severe Combined Immunodeficiency

#SevereCombinedImmunodeficiency#Antibody#Phase2#항체#면역항체+2
임상시험 11상태 DISCONTINUED
CGTBiologicTaiho Oncology, Inc.Phase 2

ASTX660 (ASTX660)

Solid Tumors; Lymphoma · Solid Tumors

#SolidTumors#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 11상태 RECRUITING
AntibodystaleShi MingPhase 2

Candonilimab (Candonilimab)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 11상태 DISCONTINUED
ADCBiologicstaleNovartis PharmaceuticalsPhase 2

CDK4/6 inhibitor+AI or fulvestrant (CDK4/6 inhibitor+AI or fulvestrant)

Salivary Gland Carcinoma; Precision Therapy · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 19.3%임상시험 11상태 RECRUITING
ADCBiologicstaleLepu Biopharma Co., Ltd.Phase 2

Becotatug Vedotin and Pucotenlimab (Becotatug Vedotin and Pucotenlimab)

Hypopharyngeal Squamous Cell Carcinoma · Nasopharyngeal Cancinoma (NPC)

#NasopharyngealCancinomaNPC#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 11상태 RECRUITING
AntibodystaleJanssenPhase 1

Topical infliximab (Topical infliximab)

Sterile Corneal Melt · Glaucoma Following Surgery

#GlaucomaFollowingSurgery#Antibody#Phase1#항체#면역항체+3
임상시험 11상태 ACTIVE

36 / 167 페이지

← 이전다음 →
전체 9,268개 프로그램 보기